Adiuva Capital

Hamburg, Germany Founded: 2011 • Age: 15 yrs
Adiuva Capital is engaged in providing equity to mid-sized companies.

About Adiuva Capital

Adiuva Capital is a Financial Services company based in Hamburg (Germany) founded in 2011. Adiuva Capital is engaged in providing equity to mid-sized companies. It operates on a Commission-Based model. Adiuva Capital has completed 1 acquisition, including ascopharm. Adiuva Capital offers products and services including Equity Investment. Its focus areas include Financials, Investment Banking and Private Equity.

Company details

Adiuva Capital is focused on supporting mid-sized companies primarily in German-speaking regions since 2011. Investments are made with a long-term perspective, utilizing capital from German investors. The company is involved in various industries, excluding war weapons, infrastructure, startups, and early-stage financing. Equity investments ranging from 10 to 100 million EUR per transaction are offered, targeting both majority and minority stakes alongside entrepreneurs. An independent entity based in Hamburg, Adiuva Capital is dedicated to fostering growth through financial and strategic support.

  • Headquarters Hamburg, Germany
  • Sectors
    Financial Services
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website adiuvacapital.de
  • Social LinkedIn
Key Metrics

Products & Services of Adiuva Capital

Adiuva Capital offers a comprehensive portfolio of products and services, including Equity Investment.

Equity Investment
Financial Services

Equity investments are provided to mid-sized companies for growth.

Investments & Acquisitions by Adiuva Capital

Adiuva Capital has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include ascopharm.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Online pharmacy for healthcare products and supplements is operated.
ascopharm.deWernigerode, Germany1977Aug 2012β€’β€’β€’β€’
Premium access

Complete acquisition details for Adiuva Capital

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Adiuva Capital

2 dated milestones of Adiuva Capital across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Adiuva Capital is founded.
  2. Acquisition Acquires ascopharm.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Adiuva Capital

Adiuva Capital was founded in 2011.

Adiuva Capital is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.

Adiuva Capital is focused on supporting mid-sized companies primarily in German-speaking regions since 2011. Investments are made with a long-term perspective, utilizing capital from German investors. The company is involved in various industries, excluding war weapons, infrastructure, startups, and early-stage financing. Equity investments ranging from 10 to 100 million EUR per transaction are offered, targeting both majority and minority stakes alongside entrepreneurs. An independent entity based in Hamburg, Adiuva Capital is dedicated to fostering growth through financial and strategic support.

Adiuva Capital offers Equity Investment.

Adiuva Capital has made 1 acquisition, including ascopharm.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available